Pharmacological management of anxiety disorders (ARCHIVED)

by Dr Zia Nadeem and Dr Allan Scott

 

Last updated: November 2016

 

Please note: This module has now been archived. It is still available to view, but please be aware when completing the module that it was last updated in 2016. A CPD certificate is available for the module, but this will be subject to the approval of your peer group.

 

Anxiety disorders are common psychiatric disorders. Despite their high prevalence rates however, they are often under-recognised and undertreated.

 

One major controversy surrounding the topic is whether anxiety disorders and depressive disorders can be reliably distinguished, or if they lie on a single continuum of affective disorders. [Read more about this in the Appendix.]

 

It is very important that anxiety disorders are clearly diagnosed and appropriately treated in accordance with the latest, critically appraised evidence for management that is currently available.

 

This module concerns the practical pharmacotherapy of the primary anxiety disorders of generalised anxiety, panic and generalised social phobia. The focus will be on the efficacy, and, to a lesser extent effectiveness of treatment. (Evidence about the cost effectiveness of drug treatment, in particular comparison with non-drug treatments, is only now becoming available).

 

Start the module

 

 

If you like this module, you may also be interested in:

 

Pharmacological treatment of resistant depression – an overview

by Professor Philip J. Cowen

 

An introduction to cognitive behavioural therapy by Dr Chris Williams and Dr Rebeca Martinez

 

 

Download take-home notes to print and annotateDownload take-home notes to print and annotate

 

Note: The information given in this module is based on the best evidence available and may not tally with prescribing guidelines.

 

 

© 2020 Royal College of Psychiatrists